Replies to post #203963 on Biotech Values

[poorgradstudent]

Blade:

Any opinion on TCON? SYRS?

No and no.

You guys follow many more companies than I do.

[DewDiligence]

TCON +9% on small license/equity deal with JNJ:

http://finance.yahoo.com/news/tracon-pharmaceuticals-announces-strategic-licensing-120000172.html

Note the clawback provision.